Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.48p
   
  • Change Today:
    -0.32p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 3,300,872
  • Market Cap: £32.58m
  • RiskGrade: 328
  • Beta: 0.87

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £96,452
Lisa Baderoon 583,963 £37,841
Tim Franklin 525,000 £34,020

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,627,001
Invesco Ltd 17,872,341 £1,158,128
Aviva Investors Global 11,285,180 £731,280
Alora Pharmaceuticals LLC 10,909,091 £706,909
M&G Investments 7,600,000 £492,480
Prudential plc 7,600,000 £492,480
Capital Income Builder 4,870,367 £315,600
Dr R Zimmer 4,551,553 £294,941
Odey Asset Management 3,433,319 £222,479
Rhone Trustees (Switzerland) SA 3,386,000 £219,413
Pictet Overseas Trust Corporation Limited 3,287,500 £213,030

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.48p
Change Today -0.32p
% Change -4.71 %
52 Week High 17.60
52 Week Low 1.50
Volume 3,300,872
Shares Issued 502.72m
Market Cap £32.58m
Beta 0.87
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 30-Jan-2026

Time Volume / Share Price
14:01 12,337 @ 6.40p
13:47 3,000 @ 6.40p
13:46 46,849 @ 6.40p
12:34 155,140 @ 6.25p
13:05 154 @ 6.50p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page